These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24665282)

  • 1. NCL Disorders: Frequent Causes of Childhood Dementia.
    Schulz A; Kohlschütter A
    Iran J Child Neurol; 2013; 7(1):1-8. PubMed ID: 24665282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NCL diseases - clinical perspectives.
    Schulz A; Kohlschütter A; Mink J; Simonati A; Williams R
    Biochim Biophys Acta; 2013 Nov; 1832(11):1801-6. PubMed ID: 23602993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human pathology in NCL.
    Anderson GW; Goebel HH; Simonati A
    Biochim Biophys Acta; 2013 Nov; 1832(11):1807-26. PubMed ID: 23200925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pheno/genotypic correlations of neuronal ceroid lipofuscinoses.
    Wisniewski KE; Zhong N; Philippart M
    Neurology; 2001 Aug; 57(4):576-81. PubMed ID: 11548735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal Ceroid Lipofuscinosis: The Increasing Spectrum of an Old Disease.
    Simonati A; Pezzini F; Moro F; Santorelli FM
    Curr Mol Med; 2014 Oct; 14(8):1043-1051. PubMed ID: 25323868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell biology and function of neuronal ceroid lipofuscinosis-related proteins.
    Kollmann K; Uusi-Rauva K; Scifo E; Tyynelä J; Jalanko A; Braulke T
    Biochim Biophys Acta; 2013 Nov; 1832(11):1866-81. PubMed ID: 23402926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A homozygous mutation in KCTD7 links neuronal ceroid lipofuscinosis to the ubiquitin-proteasome system.
    Staropoli JF; Karaa A; Lim ET; Kirby A; Elbalalesy N; Romansky SG; Leydiker KB; Coppel SH; Barone R; Xin W; MacDonald ME; Abdenur JE; Daly MJ; Sims KB; Cotman SL
    Am J Hum Genet; 2012 Jul; 91(1):202-8. PubMed ID: 22748208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum.
    Cotman SL; Karaa A; Staropoli JF; Sims KB
    Curr Neurol Neurosci Rep; 2013 Aug; 13(8):366. PubMed ID: 23775425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis.
    Fietz M; AlSayed M; Burke D; Cohen-Pfeffer J; Cooper JD; Dvořáková L; Giugliani R; Izzo E; Jahnová H; Lukacs Z; Mole SE; Noher de Halac I; Pearce DA; Poupetova H; Schulz A; Specchio N; Xin W; Miller N
    Mol Genet Metab; 2016 Sep; 119(1-2):160-7. PubMed ID: 27553878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostics and treatment of neuronal ceroid lipofuscinoses from the viewpoint of neuropediatricians].
    Steinfeld R
    Ophthalmologe; 2010 Jul; 107(7):616-20. PubMed ID: 20454899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell biology of the NCL proteins: What they do and don't do.
    Cárcel-Trullols J; Kovács AD; Pearce DA
    Biochim Biophys Acta; 2015 Oct; 1852(10 Pt B):2242-55. PubMed ID: 25962910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From gene to disease; from CLN1, CLN2 and CLN3 to neuronal ceroid lipofuscinosis].
    Taschner PE; Losekoot M; Breuning MH; Hofman I; van Diggelen OP
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):300-3. PubMed ID: 15730038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuronal ceroid-lipofuscinoses.
    Bennett MJ; Rakheja D
    Dev Disabil Res Rev; 2013; 17(3):254-9. PubMed ID: 23798013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal ceroid-lipofuscinoses: the current status.
    Goebel HH
    Brain Dev; 1992 Jul; 14(4):203-11. PubMed ID: 1443397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetics of the neuronal ceroid lipofuscinoses.
    Mole S; Gardiner M
    Epilepsia; 1999; 40 Suppl 3():29-32. PubMed ID: 10446748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain gene expression profiles of Cln1 and Cln5 deficient mice unravels common molecular pathways underlying neuronal degeneration in NCL diseases.
    von Schantz C; Saharinen J; Kopra O; Cooper JD; Gentile M; Hovatta I; Peltonen L; Jalanko A
    BMC Genomics; 2008 Mar; 9():146. PubMed ID: 18371231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal enzyme replacement therapy improves motor function and survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis.
    Lu JY; Nelvagal HR; Wang L; Birnbaum SG; Cooper JD; Hofmann SL
    Mol Genet Metab; 2015; 116(1-2):98-105. PubMed ID: 25982063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A CLN8 nonsense mutation in the whole genome sequence of a mixed breed dog with neuronal ceroid lipofuscinosis and Australian Shepherd ancestry.
    Guo J; Johnson GS; Brown HA; Provencher ML; da Costa RC; Mhlanga-Mutangadura T; Taylor JF; Schnabel RD; O'Brien DP; Katz ML
    Mol Genet Metab; 2014 Aug; 112(4):302-9. PubMed ID: 24953404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and genetic description of neuronal ceroid lipofuscinosis 6 type in the yakut family].
    Golikova PI; Petukhova DA; Sukhomyasova AL; Nikolaeva TY; Gurinova EE; Ivanova RN; Maksimova NR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(8):71-76. PubMed ID: 34481439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal ceroid lipofuscinoses.
    Jalanko A; Braulke T
    Biochim Biophys Acta; 2009 Apr; 1793(4):697-709. PubMed ID: 19084560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.